Number of Ontarians taking stimulants more than doubled after pandemic, study finds

The number of adults in Ontario initiating stimulant medications (primarily for ADHD) more than doubled following the COVID-19 pandemic, with women comprising the largest share of new users. The study highlights a sustained rise in adult stimulant starts post-pandemic but does not report direct financial, regulatory, or market consequences.

Analysis

The number of adults in Ontario initiating stimulant medications (primarily for ADHD) more than doubled following the COVID-19 pandemic, with women comprising the largest share of new users. The study highlights a sustained rise in adult stimulant starts post-pandemic but does not report direct financial, regulatory, or market consequences.